Professional Poster - Browse by Category

4-015 - Application of kaizen philosophy to improve pharmacy operations in a community hospital

4-004 - Courtesy medication assistance

4-016 - Financial impact of ambulatory care pharmacists in primary care

4-007 - Implementation of a radiofrequency tagging system to manage drug kits and trays

4-006 - Implementation of premixed bivalirudin in a community-hospital cardiac catheterization laboratory

4-005 - Improving bedside medication delivery program to increase prescription capture rate and expedite patient discharges

4-001 - Incidence of burnout in critical care pharmacists

4-017 - Increasing operational efficiency and drug cost savings by partnering with a regional GPO and unit-dose packaging vendor

4-002 - Innovative residency and fellowship program narrows leadership gap: a view from key stakeholders

4-010 - Optimizing purchases by leveraging sub-wholesale acquisition cost contract pricing at a 340B covered entity

4-013 - Post-implementation analysis: impact of intravenous automation systems on health-system pharmacy operations

4-012 - Quantifying costs of high dollar pharmaceutical expenditures in light of a 340B drug pricing program in a county health system

4-011 - Rationale and cost savings of a conversion to fluticasone-vilanterol inhaler in a large health system

4-003 - Sterile compounding workflow optimization to conserve fluids and reduce waste in the setting of drug shortages through the use of IV workflow software

4-018 - Strategy to eliminate waste with metered dose inhalers (MDIs) in adult chronic obstructive pulmonary disease (COPD) patients in an acute care community hospital

4-009 - Transition from intravenous infusion to intravenous push administration of selected antibiotics as a clinically neutral cost savings measure

4-014 - Utilizing purchase data to compare opioid usage between acute care facilities within a regional group purchasing organization

7-015 - Assessing the landscape of clinical pharmacy services in federally qualified health centers

7-007 - Associated unilateral facial swelling and skin rash in a patient on warfarin

7-017 - Association between anticoagulation clinic visit compliance and therapeutic international normalized ratio (INR) result

7-013 - Best practices for safe use of SGLT-2 inhibitors developed from an expert panel Delphi consensus process

7-004 - Characteristics of adults with a history of uncontrolled type 2 diabetes within a federally qualified health center

7-001 - Clinical and financial outcomes for a multidisciplinary chronic obstructive pulmonary disease (COPD) clinic — two years of experience

7-002 - Clinical and financial outcomes for a multidisciplinary heart failure clinic — three years of experience

7-003 - Clinical and financial outcomes for a multidisciplinary transitions of care program and clinic

7-011 - Clinical response to generic fluticasone propionate/salmeterol multidose, dry-powder inhaler in asthma patients managed at an ambulatory care practice setting

7-019 - Counseling referrals and abstinence for veterans enrolled in smoking cessation (CRAVES)

7-005 - Evaluation of pharmacist intervention on closure of quality gaps in a merit based payment system within an accountable care organization (ACO)

7-009 - Hepatitis C virus treatment with elbasvir/grazoprevir in a diverse patient population at an urban academic medical center

7-010 - Implementation of pharmacy services in a home health program

7-012 - Implementation of pharmacy services in an outpatient heart failure clinic

7-016 - Improving diabetes self-management via pharmacist run diabetes education group classes

7-020 - Knowledge, confidence, and motivations of pharmacists in providing tobacco cessation services

7-021 - Pharmacist driven hepatitis B screening and/or vaccination in patients treated for hepatitis C

7-006 - Pharmacists role in pain management of pediatric patients after tonsillectomy after discharge

7-014 - Prescribing patterns of patients with type 2 diabetes from a federally qualified health center

7-018 - Reducing infusion wait time for patients with infusion only appointments: a pilot to premix continuing oncology medications

7-008 - Role of pharmacists in reducing heart failure readmissions in the community setting

4-037 - Analysis of a large U.S. national study of patient satisfaction during a recent venous thromboembolism episode

4-029 - Analysis of cost-effectiveness of betrixaban compared with enoxaparin for prophylaxis of venous thromboembolism in nonsurgical patients with acute medical illness in the United States

4-022 - Anticoagulant therapy utilization pathways in patients with recent venous thromboembolism

4-036 - Assessing the impact of sacubitril/valsartan on cardiovascular remodeling parameters

4-024 - Body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in atrial fibrillation patients undergoing percutaneous coronary intervention: RE-DUAL PCI

4-021 - Clinical pharmacist interventions in the management of hospitalized patients on warfarin

4-023 - Comparison of two weight caps in an anti-Xa based heparin protocol

4-035 - Development and implementation of a novel tool for med-induced QTc monitoring and review of physician feedback

4-020 - Does body mass index (BMI) influence warfarin dosing requirements? a retrospective cross-sectional study from Qatar

4-028 - Dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after percutaneous coronary intervention in patients with atrial fibrillation and diabetes mellitus

4-025 - Effective reversal of dabigatran anticoagulation by idarucizumab in patients with renal impairment

4-032 - Evaluating the dose of heparin in acute limb ischemia

4-038 - Impact of a change in preferred pharmacologic nuclear stress testing agent from regadenoson to adenosine in a community hospital

4-026 - Impact of direct oral factor-Xa inhibitors on therapeutic unfractionated heparin monitoring in an anti-factor Xa based protocol

4-027 - Impact of renal function on dual antithrombotic therapy with dabigatran in patients with atrial fibrillation undergoing percutaneous coronary intervention: RE-DUAL PCI

4-033 - Patient characteristics and statin prescribing patterns after an acute cardioembolic stroke

4-030 - Risk of cardiovascular events in patients with rheumatoid arthritis in a Texas population

4-019 - Sacubitril/valsartan coverage and Medicare Part D beneficiaries: the early years

4-031 - Understanding patient's access to care barriers in the treatment of venous thromboembolism

4-034 - Vasospastic myocardial infarction following use of synthetic marijuana

7-025 - Correlation of clinical outcomes with glucose test strip dispensing in patients with stable type 2 diabetes in a Veterans Health Administration Hospitals network

7-023 - Impact of a novel, pharmacist-led digital medicine program on medication adherence and hospital utilization in heart failure patients

7-024 - Impact of a pharmacist-led antibiotic audit program at two long term care facilities

7-026 - Impact of a value-based insurance design on chronic obstructive pulmonary disease (COPD) medication adherence and health care utilization

7-022 - Knowledge and practice of Lebanese community pharmacists in the self-management of low back pain: a cross sectional study

7-029 - Advancing the role of pharmacy technicians to improve discharge medication bedside delivery

7-033 - Evaluating the effects of a multidisciplinary transition care management program on hospital readmissions

7-032 - Impact of short messaging service (SMS) technology in patient outcomes with specialty chronic diseases at a specialty pharmacy

7-030 - Implementation of a comprehensive transitions of care stewardship bundle initiative on Clostridium difficile infection management

7-028 - Improved patient access to HCV treatment: DAA inclusion across state Medicaid formularies one year later in 2018

7-034 - Parental acetaminophen use analysis at a community teaching hospital

7-031 - Population health service: utilizing care support resources to improve care

7-027 - Practice development: Implementation of pharmacist-managed early switch from IV to PO therapy using electronic identification at a tertiary academic hospital

7-035 - Preliminary results of a national public survey on the perception of pharmacists and the barriers to utilizing pharmacy services

4-051 - Adult patients experiencing mild or moderate atopic dermatitis are significantly impacted by their condition: results from a real-world study in the United States

4-041 - Characterization of adults with type 2 diabetes and controlled glycemia: a comparison of lifestyle management versus anti-hyperglycemic treatment

4-048 - Cost-saving opportunities among hospitalized community-acquired pneumonia patients treated with omadacycline, an aminomethylcycline antibiotic with IV and oral formulations, compared to ceftriaxone and macrolide therapy

4-049 - Cost-savings analysis with use of omadacycline among hospitalized community-acquired pneumonia patients at risk of Clostridium difficile infection being treated with moxifloxacin: budget impact model findings

4-047 - Effect of an insulin pump orderset on the safety and efficacy of insulin pumps in hospitalized patients

4-053 - Effect of patiromer on serum potassium in hyperkalemic patients with severe chronic kidney disease on RAAS inhibitors: results from OPAL-HK and AMETHYST-DN

4-042 - Forced vital capacity response to 2.5 microgram tiotropium Respimat in adult patients with moderate or mild symptomatic asthma

4-050 - Gastrointestinal tract recovery in patients undergoing selected surgical procedures

4-040 - Long-term effect of tiotropium plus olodaterol fixed-dose combination therapy on heart rate and blood pressure in chronic obstructive pulmonary disease patients

4-052 - Preliminary evaluation of addition of transgender patient care into a doctorate of pharmacy curriculum

4-039 - Risk of diabetic ketoacidosis in patients with type II diabetes mellitus upon dapagliflozin initiation

4-045 - Therapeutic interchange protocol of orally inhaled medications to administration via nebulizer: effect on workload of respiratory therapists and registered nurses

4-046 - Therapeutic interchange protocol of orally inhaled medications to administration via nebulizer: financial impact

4-044 - Therapeutic interchange protocol of orally inhaled medications to administration via nebulizer: impact on the incidence and cost of wasted doses

4-043 - Therapeutic interchange protocol of orally inhaled medications to administration via nebulizer: impact on the incidence of therapeutic duplication

7-036 - Analysis of adverse drug reactions in surgical intensive care unit at tertiary care teaching hospital in Korea

7-037 - Effects of designated pharmacist on intervention and cost avoidance in the surgical intensive care unit

4-071 - Assessment of adherence to restrictive guidelines for conivaptan administration at a community hospital

4-054 - Benzodiazepines safety and effectiveness in alcohol withdrawal management in medical ward

4-067 - Case control study about the risk of pancreatic cancer with dipeptidyl peptidase-4 inhibitors (DPP4I) in Lebanon

4-062 - Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a U.S. linked claims and EMR database analysis

4-068 - Cost savings initiatives for infliximab use in a county hospital system

4-069 - Curtailing the use of high risk medications in the elderly at a county health system

4-058 - Evaluation of the prophylactic use of proton pump inhibitors in hospital settings

4-065 - Interaction between placitaxel and clopidogrel: relevance in clinical practice

4-066 - Medication utilization evaluation and prescribing patterns of direct oral anticoagulants

4-064 - Multi-faceted effects of SGLT2 inhibitor in diabetic patients with metabolic liver disease

4-073 - Patterns of prescribing neuropathic pain drugs in the Lebanese community: a cross-sectional study

4-059 - Potentially inappropriate medication prescribing in elderly patients with chronic kidney disease: an observational study

4-061 - Prevalence and clinical consequences of contraindicated repaglinide-gemfibrozil interaction in an ambulatory setting

4-056 - Proton pump inhibitors utilization and hospital acquired Clostridium difficile infections in a community teaching hospital

4-057 - Retrospective evaluation and tracing of heparin infusion protocol use in a community hospital (RETRO-HEP)

4-070 - Retrospective study investigating the adherence to guidelines in using albumin for inpatients in Lebanese hospitals

4-060 - Review of oral anticoagulant use in a community hospital

4-072 - Shortage-related requests received by a drug information center: a descriptive analysis of affected drugs and resources supporting recommendations for management

4-055 - The impact of adherence to antidiabetic medications on the Quailty of life (QoL) of diabetic patients in Dmmam Saudi Arabia

4-063 - The impact of implementation of a medication algorithm for drug-naive patients with type 2 diabetes mellitus in an academic teaching hospital in Japan

4-074 - Validity of utilization and efficacy of teriparatide prescription

7-045 - Assessing acute pain management in the emergency department in a Lebanese hospital

7-043 - Decreasing opioid use for the treatment of headache and migraine in the emergency department and the effect on revisit rate

7-044 - Drug related problems in emergency department at a major tertiary hospital in Riyadh, Saudi Arabia: a prospective, observational study

7-039 - Evaluation of urinary tract infection treatment in a community hospital emergency department

7-038 - Free-standing emergency departments without pharmacy onsite: how one team provided high-level patient care virtually

7-040 - Opioid prescribing at emergency department discharge for headache and migraine following implementation of an opioid-free acute management algorithm

7-041 - Organized chaos: precepting in a community hospital emergency department

7-042 - Team approach to stroke center certification improves fibrinolytic door-to-needle time in acute ischemic stroke

7-047 - Nitrofurantoin use in frail, community-dwelling, older adults with renal impairment: a retrospective chart review on safety and efficacy

7-048 - Pharmacist interventions involving patient outreach: early findings of patient outcomes in older adults

7-049 - Prescribing patterns and healthcare costs among patients with gout

7-046 - Utilization of quetiapine during hospitalization and at discharge

7-050 - Incidence, nature and causes of medication errors at home healthcare in Qatar

4-107 - Assessment of an antimicrobial stewardship program one year after implementation in a community hospital

4-108 - Cost-benefit of inpatient pharmacist administered penicillin allergy skin testing

4-112 - De novo hepatocellular carcinoma (HCC) and HCC recurrence in hepatitis C virus patients treated with oral direct-acting antiviral and interferon-based regimens

4-103 - Does utilization increase when a brand name antibiotic goes generic?

4-078 - Duration of therapy in community-acquired pneumonia (CAP) and the role of procalcitonin

4-082 - Economic burden of bloodstream infection among those who survive or die during the inpatient hospitalization: analysis of 2015 National Inpatient Sample

4-095 - Efficacy of posaconazole delayed-release tablet for prevention of invasive fungal disease during chemotherapy-induced neutropenia

4-085 - Evaluating the impact of opioids on length of stay in patients with Clostridium difficile infections

4-094 - Evaluating the increase in carbapenem use in a large, tertiary care, metropolitan hospital with antibiotic utilization monitoring by the antibiotic stewardship program (ASP)

4-089 - Evaluation of a pharmacist-led urgent care antimicrobial stewardship program

4-076 - Evaluation of Acinetobacter baumannii pneumonia among critically ill patients in a tertiary care hospital in Saudi Arabia

4-088 - Evaluation of antibiotic prescribing for acute otitis media in children in a rural outpatient setting

4-113 - Evaluation of renal and bone and safety in patients with CHB and chronic kidney disease treated with tenofovir alafenamide in post liver transplantation

4-084 - Evaluation of the development of acute kidney injury in patients receiving piperacillin-tazobactam with concomitant vancomycin or telavancin

4-110 - Health economic value of plazomicin versus colistin in the treatment of carbapenem-resistant enterobacteriaceae bloodstream infections: a cost-effectiveness analysis

4-111 - Health economic value of plazomicin vs. meropenem in the treatment of complicated urinary tract infections including acute pyelonephritis: cost-effectiveness analysis

4-097 - Impact of a levofloxacin restriction program on utilization in a community hospital

4-098 - Impact of a pharmacist-driven methicillin-resistant staphylococcus aureus (MRSA) nasal polymerase chain reaction ordering protocol on the duration of antibiotic therapy for pneumonia

4-105 - Impact of a small and rural hospital antimicrobial stewardship alliance on regulatory compliance

4-086 - Impact of a urinary tract infection treatment pathway on antimicrobial prescribing within a community hospital

4-099 - Impact of an antimicrobial stewardship initiative to decrease the use of fluoroquinolones in the treatment of urinary tract infections in hospitalized patients

4-080 - Impact of an antimicrobial stewardship-focused advanced pharmacy practice experience (APPE) on a vancomycin drug monitoring service

4-075 - Impact of antimicrobial stewardship on appropriate initiation of antibiotic therapy

4-091 - Impact of antimicrobial stewardship program implementation on antibiotic expenditures, bacterial resistance, and Clostridium difficile incidence at a suburban community hospital

4-077 - Impact of implementing a pharmacist driven intervention antimicrobial stewardship report in the incidence of healthcare associated clostridium difficile infections

4-083 - Impact of vancomycin loading doses on methicillin resistant staphylococcus aureus (MRSA) minimum inhibitory concentrations

4-109 - Implementation of a meropenem dose optimization protocol in a long-term acute care hospital

4-101 - Implementation of an antimicrobial stewardship program (ASP) in a 300-bed, acute care, teaching hospital: three years later

4-102 - Implementation of an antimicrobial stewardship program for nursing home patients

4-079 - Implementation of an antimicrobial stewardship prospective audit strategy in a critical access hospital

4-092 - Infectious endocarditis by staphylococcus aureus: adequacy of treatment and morbimortality

4-104 - Microbiological profile and escherichia coli resistance patterns in diabetic foot infections and urinary tract infections among Lebanese patients

4-100 - Reducing fluoroquinolone usage by partnering with the microbiology lab

4-115 - Referral source matters: hepatitis C cascade of care for traditional versus emergency department referrals

4-081 - Risk of acute kidney injury in patients on concomitant vancomycin and piperacillin-tazobactam compared to those on vancomycin and cefepime at a community hospital

4-106 - Risk of nephrotoxicity with the use of piperacillin-tazobactam: retrospective analysis in a community hospital

4-090 - Sepsis rapid response team performance improvement initiative

4-093 - Sustained virologic response rates after hepatitis C virus treatment in patients born between 1945 and 1965

4-096 - TeleStewardship services in combination with rapid blood pathogen detection increased antimicrobial stewardship interventions and improved compliance with Joint Commission Standards for Antimicrobial Stewardship

4-087 - The prevalence of all types of infections among schizophrenic patients residing in a Lebanese teritary hospital

4-114 - Utilizing days of therapy per 1000 patient days to further develop an antimicrobial stewardship program on a transition of care unit

7-057 - An evaluation of inappropriate fluoroquinolone prescribing after the implementation of a best practice alert (BPA) in an integrated delivery system

7-058 - Assessment of the impact and efficacy of alternative therapy alerts as a drug shortage management strategy

7-056 - Burden of intravenous compounding errors and impact of gravimetric verification based intravenous preparation workflow solution

7-054 - Comparison of medication errors detected at small versus large hospital sites utilizing technology-assisted workflow

7-055 - Compounded sterile product preparation time at small compared to large hospital sites utilizing technology-assisted workflow

7-051 - Impact of patient-controlled analgesia (PCA) smart pump-electronic health record (EHR) interoperability with auto-documentation on chart completion in a community hospital setting

7-052 - Impact of smart pump-electronic health record (EHR) interoperability with auto-documentation on infusion-therapy common procedural terminology (CPT) code billing claims at a community hospital

7-053 - Integration of automated dispensing and inventory systems provides monthly inventory monitoring and improved inventory turns in a community hospital pharmacy

7-059 - Utilization of a clinical decision support tool in automated medication dispensing cabinets to promote dysphagia screening for ischemic stroke patients with a multidisciplinary team approach

7-062 - Analysis of the compatibility of clonidine with frequently used drugs in intensive care units

7-064 - Evaluation of two closed system transfer devices based on the proposed National Institute for Occupational Safety and Health performance test protocol

7-060 - Syringe size utilization in very low flow rate infusions: an analysis of programmable syringe pump data

7-063 - Using smart pump continuous quality improvement (CQI) data to improve clinical outcomes and cost efficiency

7-061 - Utilization of smart pump syringe delivery and wireless drug library updates to mitigate the impact of intravenous solution shortages

7-065 - Impact of a simulation-based activity in total parenteral nutrition (TPN) education in a doctor of pharmacy (PharmD) program

7-072 - Benefits of a health-system pharmacist-controlled oral chemotherapy medication therapy disease management program

7-076 - Comparison of pegfilgrastim and filgrastim for the prophylactic effect for preventing febrile neutropenia in patients undergoing rituximab with etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin treatment

7-068 - Convenience of nivolumab fixed dose schedule

7-069 - Dose rounding policy results in significant cost savings

7-071 - Economic modeling for the U.S. of intravenous versus subcutaneous rituximab as single-agent maintenance therapy in follicular lymphoma

7-074 - Health moves us towards treatment reconciliation for oncologic patients

7-075 - Real-world efficacy and safety of osimertinib: a single institutional experience

7-066 - Relationship between epidermal growth factor receptor mutations and skin disorders in patients receiving epidermal growth factor receptor - tyrosine kinase inhibitors

7-073 - Risk factors for febrile neutropenia among patients receiving preoperative or postoperative chemotherapy for breast cancer

7-070 - Sensitivity to granulocyte colony stimulating factors in cancer patients

7-067 - Utilization of mutation testing and targeted treatments in non-small cell lung cancer in a large integrated health system

4-116 - Pharmacokinetic-pharmacodynamic relationship observed with the investigational extended-release, non-opioid analgesic HTX-011

4-117 - Self-assessment of neuropathic pain treatment among patients with cervical or lumbar radiculopathy in Lebanon

4-118 - Use of opioids before and after common elective surgical procedures: an analysis of Aetna fully insured commercial and Medicare populations

7-079 - Assessment of the cumulative AUC (cAUC) for busulfan (Bu) and donor-cell chimerism in the pediatric alloHCT population with non-malignant disorders

7-080 - Comparison of posaconazole suspension and delayed release tablets in pediatric hematology/oncology patients

7-077 - Improved palivizumab utilization for respiratory syncytial virus (RSV) prophylaxis pre- and post-implementation of a pharmacist clinical screening tool

7-078 - Parental knowledge, attitudes and beliefs on fever: a cross-sectional study

7-084 - A quantitative study on usage and effect of thrombolytic agent in MI patients at tertiary care hospital

7-081 - Amikacin pharmacokinetics in geriatric patients treated large dose extended interval(LDEI) and recommendation of initial dosage regimen

7-082 - Effect of age on the pharmacokinetic profile of subcutaneous C1-esterase inhibitor in the treatment of hereditary angioedema

7-083 - Pharmacokinetics of synthetic cathinones found in 'bath salts' in mouse brain and plasma using liquid chromatography-mass spectrometry

7-085 - Impact of a multi-step action plan to enhance the medication error reduction plan in a critical access hospital in California

7-086 - Lessons learned in USP <797> and <800> upgrades in a rural Connecticut hospital

7-087 - Student pharmacists knowledge of adverse event reporting and its place in the curriculum

4-121 - Implementation of a pharmacy validation technician program

4-120 - Increased emergency department order processing by using remote support staff

4-119 - Optimizing patient care by utilizing a pharmacy techinician in ambulatory settings

7-099 - A synchronous interprofessional patient safety simulation integrating distance learners

7-096 - Analyzing preceptor opinions regarding two scheduling formats of inpatient clinical skills IPPE to improve educational outcomes

7-095 - Characterization, management, and matriculation of challenging pharmacy residents: a national survey of residency preceptors and program directors

7-093 - Community engagement opportunities during rotations: outcomes from a community needs assessment approach

7-089 - Creation of a unique non-patient care rotation for a resident on light duty

7-098 - Delivering interprofessional education through problem-based learning: a collaboration among six health professions institutions

7-090 - Development and implementation of a staffing checklist for PGY1 residents and pharmacy staff in discordant rotation schedules

7-103 - Effect of nursing education and attender’s counselling on medication errors: an interventional study

7-094 - Employment outcomes of a rural health training program: a nine-year longitudinal tracking study

7-092 - Evaluation of a pharmacist education program with interventions and readmission rates

7-088 - Evaluation of objective structured clinical examination (OSCE) in faculty of pharmacy at King Abdulaziz University (KAU)

7-102 - Evaluation of three American Pharmacists Association professional certificate training programs in a pharmacy curriculum using a graduating class survey

7-097 - Pharmacy student perspectives of computerized exam software

7-104 - Second-year data regarding rates and correlates of depressive symptoms in pharmacy residents

7-101 - Student perceptions of midterm exam and end-of-semester remediation policies

7-100 - To certify or not to certify? impact of ACLS training

7-091 - Utilization of a pharmacy resident driven newsletter to provide education for healthcare providers

4-123 - Current status of residency-trained pharmacists in Saudi Arabia

4-122 - Impact of continuous professional pharmacy development at Hamad Medical Corporation, Qatar

4-127 - Impact of student involvement on attainment of an initial interview for postgraduate training programs in a graduating class of P4 pharmacy students

4-125 - Implementation of a pharmacy technician training program within a multi-hospital healthcare system

4-124 - Perceived stress and discrimination among working pharmacist moms

4-126 - Preparing pharmacy students to respond to ethical dilemmas encountered in practice using the format of an interdisciplinary ethics quiz bowl

7-105 - Adherence to evidence-based care in stroke Lebanese survivors: an observational study

7-110 - Aripiprazole lauroxil nanocrystal dispersion: a potential one-day initiation regimen for long-acting aripiprazole lauroxil

7-108 - Combination of buprenorphine and samidorphan for the treatment of depression

7-106 - Dronabinol for the treatment of agitation and aggressive behavior in a hospitalized patient with schizoaffective disorder

7-107 - Evaluation of pharmacy students’ perspectives on mental health stigma throughout the four professional years of the doctor of pharmacy program

7-109 - Justifying implementation of a prescription drug misuse course: pharmacy evaluation of prescription drug misuse and marijuana abuse by adolescent males from a residential treatment center

7-115 - Analysis of pharmacist-led interventions on prescribing errors for rational drug use in a tertiary hospital

7-122 - Analysis of the represcription rate and adverse drug reactions (ADR) recurrence rate of previously ADR-reported drugs, after changing ‘criteria of ADR warning sign’

7-113 - Assessment of glycosylated hemoglobin (A1C) and foot examinations in low-income, uninsured patients with diabetes and efficiency of performing screenings in a free health clinic

7-111 - Exploring facilitators and barriers to medication error reporting among healthcare professionals in Qatar using the theoretical domains framework: a mixed-methods approach

7-123 - High-risk opioid prescribing when multiple prescribers are involved

7-121 - Identifying the use of ambulatory pharmaceutical pumps by hospitalized patients: implementation of electronic pharmacist notification triggered by nursing admission assessment

7-126 - Incorrect updates in the shared medication profile when patients are discharged from hospital

7-120 - Medication mismanagement: medication errors and adverse drug events associated with complexities organizing and administering medications in U.S. adults

7-114 - Operating room (OR) pharmacy remodel preparation and implementation using lean six sigma concepts leads to decreased errors and inventory

7-112 - Perspectives of healthcare professionals in Qatar on causes of medication errors: a mixed methods study of safety culture

7-124 - Pilot studies of safe handling and disposal of oral anticancer chemotherapy

7-118 - Practice gap analysis for the subcutaneous insulin management at a community teaching hospital compared to the 2017 Institute for Safe Medication Practices (ISMP) guidelines

7-116 - Safe management of sepsis and septic shock in the emergency department

7-117 - Standardized prescription medication directions at a specialty pharmacy

7-119 - Zero-harm: embracing a concept, empowering your staff

7-127 - Implementation of an antibiotic order set to improve indication documentation in a pediatric behavioral health facility

7-128 - Effect of initiation of benznidazole on tacrolimus levels post-heart transplant

4-129 - Multi-center prospective study of breast cancer screening knowledge, attitude, and practice in hospital employed Lebanese women

4-128 - Potential risk of herb-drug interactions during pregnancy: a cross-sectional survey